Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|13|1531-1544

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.13, 2010-05, pp. : 1531-1544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy in Disorders of Lipoprotein Metabolism

By  

Current Gene Therapy, Vol. 7, Iss. 1, 2007-02 ,pp. : 35-47

Bentham Science Publishers

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitor (Statin) Therapy and Coronary Atherosclerosis in Japanese Subjects: Role of High-Density Lipoprotein Cholesterol

By Tani Shigemasa   Nagao Ken   Hirayama Atsushi  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 411-417

Adis International

Access to resources Recommend Favorite

Therapeutic use of the high-density lipoprotein protein and peptides

By Marchesi Marta   Sirtori Cesare R  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 227-241

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1494-1503

Bentham Science Publishers

Access to resources Recommend Favorite

High-Density Lipoprotein-Raising Strategies: Update 2010

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1517-1530

Bentham Science Publishers

Access to resources Recommend Favorite